Zimulti (Rimonabant)

Zimulti is used complementary to diet and exercise to treat obese or overweight patients who suffer from Type 2 diabetes and abnormal levels of fat in the blood. It can also prevent the risk of cardiovascular disease.

The usual dose is one 20 mg tablet to be taken once daily in the morning before breakfast. Swallow the tablet whole.

Zimulti is a contemplated brand name for Rimonabant, intended for its launch in the US. It has not yet been made saleable in the US market. Acomplia is a brand name for Rimonabant in the UK and rest of Europe, which was launched in June 2006.

It is advisable to consult a doctor before taking Zimulti and adhere to the prescribed dosage to attain the expected results. Zimulti should not be taken by pregnant woman since it may cause birth defects in an unborn baby. Zimulti should not also be used by lactating mothers. Though not clinically proved, there is possibility that this diet pill may be passed into breast milk. Zimulti is metabolized by the liver, so it is recommended that patients with moderate hepatic impairment should consult their healthcare provider before using the drug.

Frequently asked questions about Zimulti

As your body adjusts to the Zimulti Drug, you may experience some of the reported side effects like anxiety, disorientation, insomnia, nausea, headache, hallucinations, hypertension, heart and kidney damage, palpitations, heart attack, strokes, psychosis, fatigue and hyperphagia (excessive eating beyond normal feeling of hunger), gastrointestinal discomfort and dizziness.